« FDA Gives Tentative Approval to New Generic AIDS Drug in | Main | FDA Approvals - Aspreva and Roche Receive Orphan Drug Designation from FDA for »

FDA Approvals - Novartis' biogeneric wins breakthrough approval from FDA (Pharmaceutical Business Review)


Novartis' biogeneric wins breakthrough approval from FDA (Pharmaceutical Business Review)
In a landmark decision the FDA has approved Novartis biogeneric drug Omnitrope for the treatment of growth disorders in children and adults.

Increased Survival and High Response Rates Reported for Introgen's ADVEXIN P53 Therapy (RedNova)
ATLANTA, June 5 /PRNewswire-FirstCall/ -- Researchers at Introgen Therapeutics, Inc.
 

©2006 FDA-News.com. All rights reserved.